Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-55.16	31.03	69.22
Graham Fair Price	46.05	13.39	9.17
PEG	-60.46	1.08	-2.73
Price/Book	-9.86	1.67	1.85
Price/Cash Flow	-42.17	48.08	83.15
Prices/Earnings	-54.93	116.83	259.21
Price/Sales	-54.93	5.62	12.46
Price/FCF	-42.17	48.08	83.15
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-5.92	0.62	0.66
Operating Margin	6.67	0.07	0.06
ROA	100.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	100.00
ROIC	< 0.005	0.01	114.68
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.01	0.03	-58.00
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	-0.83	1.13	36.91
EPS QOQ	-0.95	1.08	14.01
FCF QOQ	20.95	0.56	-97.33
Revenue QOQ	-0.49	1.00	105.88
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	205.06	91.96	-55.15
Days Sales Outstanding (DSO)	51.91	38.53	-25.78
Inventory Turnover	0.44	0.98	122.98
Debt/Capitalization	0.25	0.25	-1.89
Quick Ratio	0.65	0.81	24.72
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	45.79	47.29	3.28
Cash	4.71	5.11	8.42
Capex	-0.29	-0.83	-188.81
Free Cash Flow	1.02	1.64	61.00
Revenue	6.79	14.03	106.55
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.32	1.32	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	7.89	3.94	-50.01
Naive Interpretation	Member

06 - Financial Health · Weak

Rating